Click to Share
 

Biologics CDMO In US Press Releases

Exclusive News
Topics Locations Industries Dates

By P&S Intelligence
The U.S. biologics CDMO market is set to grow at an 11.7% CAGR, reaching $9.08B by 2032, driven by rising biologics demand, aging population, and tech advancements.

Page updated every 10 minutes
Trending
Most Viewed
Daily News


Like PRLog?
9K2K1K
Click to Share